Zomedica Corp. (ZOM) News & Overview - Discounting Cash Flows
ZOM
Zomedica Corp.
ZOM (AMEX)

ZOM's Business Model

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.
Sector & Industry Healthcare / Drug Manufacturers - Specialty & Generic
Website https://www.zomedica.com
CEO (Chief Executive Officer) Larry C. Heaton II
Number of Employees
IPO date November 21, 2017

ZOM Latest News

Contact
CountryUS
Address100 Phoenix Drive
CityAnn Arbor
StateMI
Phone734 369 2555
Zip Code48108
Other Identifiers
CIK0001684144
ISINCA98980M1095
CUSIP98980M109
Open0.092
Previous Close0.0975
Volume790.9 Thou.
Average Volume8.54 Mil.
Day’s Range0.092 – 0.0973
52 Week Range0.0151-0.1952
MA (50)0.11441
MA (200)0.12976
Market Cap95.35 Mil.
Shares Out.980 Mil.
Earnings DateMar 13, 2025
Beta
Last Dividend
EPS
PE

Industry Competitors for ZOM

discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us